YULIN PENG
Broker in Waltham, MA
License number
Massachusetts 9086914
Issued Date
Mar 11, 2006
Expiration Date
Aug 11, 2007
Type
Salesperson
Address
Address
Waltham, MA 02453
Professional information
6-11 Bridged Oxime Erythromycin Derivatives
US Patent:
2010004, Feb 18, 2010
Filed:
Aug 18, 2009
Appl. No.:
12/543155
Inventors:
Guoqiang Wang - Belmont MA, US
Ly Tam Phan - Quincy MA, US
Yat Sun Or - Watertown MA, US
Yao-Ling Qiu - Andover MA, US
Deqiang Niu - Lexington MA, US
Yulin Peng - Waltham MA, US
Marina Busuyek - Center Valley PA, US
Yanchun Wang - Newton MA, US
Suanne Nakajima - Winchester MA, US
Ly Tam Phan - Quincy MA, US
Yat Sun Or - Watertown MA, US
Yao-Ling Qiu - Andover MA, US
Deqiang Niu - Lexington MA, US
Yulin Peng - Waltham MA, US
Marina Busuyek - Center Valley PA, US
Yanchun Wang - Newton MA, US
Suanne Nakajima - Winchester MA, US
International Classification:
A61K 31/7048, C07H 17/08
US Classification:
514 29, 536 74
Abstract:
The present invention discloses compounds of formula I, or pharmaceutically acceptable salts, esters, or prodrugs thereof:which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of antibiotic treatment. The invention also relates to methods of treating a bacterial infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The invention further includes processes by which to make the compounds of the present invention.
6-11 Bridged Oxime Erythromycin Derivatives
US Patent:
2006025, Nov 9, 2006
Filed:
May 4, 2005
Appl. No.:
11/122251
Inventors:
Guoqiang Wang - Belmont MA, US
Ly Phan - Quincy MA, US
Yat Or - Watertown MA, US
Yao-Ling Qiu - Andover MA, US
Deqiang Niu - Lexington MA, US
Yulin Peng - Waltham MA, US
Marina Busuyek - Natick MA, US
Yanchun Wang - Newton MA, US
Suanne Nakajima - Arlington MA, US
Ly Phan - Quincy MA, US
Yat Or - Watertown MA, US
Yao-Ling Qiu - Andover MA, US
Deqiang Niu - Lexington MA, US
Yulin Peng - Waltham MA, US
Marina Busuyek - Natick MA, US
Yanchun Wang - Newton MA, US
Suanne Nakajima - Arlington MA, US
International Classification:
C07H 17/08, A61K 31/7052
US Classification:
514028000, 536007400
Abstract:
The present invention discloses compounds of formula I, or pharmaceutically acceptable salts, esters, or prodrugs thereof:
which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of antibiotic treatment. The invention also relates to methods of treating a bacterial infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The invention further includes processes by which to make the compounds of the present invention.
6-11 Bridged Oxime Erythromycin Derivatives
US Patent:
2006025, Nov 9, 2006
Filed:
May 3, 2006
Appl. No.:
11/416609
Inventors:
Guoqiang Wang - Belmont MA, US
Ly Phan - Quincy MA, US
Yat Or - Watertown MA, US
Yao-ling Qiu - Andover MA, US
Deqiang Niu - Lexington VA, US
Yulin Peng - Waltham MA, US
Marina Busuyek - Center Valley PA, US
Yanchun Wang - Newton MA, US
Suanne Nakajima - Winchester MA, US
Ly Phan - Quincy MA, US
Yat Or - Watertown MA, US
Yao-ling Qiu - Andover MA, US
Deqiang Niu - Lexington VA, US
Yulin Peng - Waltham MA, US
Marina Busuyek - Center Valley PA, US
Yanchun Wang - Newton MA, US
Suanne Nakajima - Winchester MA, US
International Classification:
A61K 31/7052, C07H 17/08
US Classification:
514028000, 536007400
Abstract:
The present invention discloses compounds of formula I, or pharmaceutically acceptable salts, esters, or prodrugs thereof:
which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of antibiotic treatment. The invention also relates to methods of treating a bacterial infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The invention further includes processes by which to make the compounds of the present invention.
6-11 Bridged Oxime Erythromycin Derivatives
US Patent:
2008026, Oct 23, 2008
Filed:
May 20, 2008
Appl. No.:
12/123874
Inventors:
Guoqiang Wang - Belmont MA, US
Ly Tam Phan - Quincy MA, US
Yat Sun Or - Watertown MA, US
Yao-Ling Qiu - Andover MA, US
Deqiang Niu - Lexington MA, US
Yulin Peng - Waltham MA, US
Marina Busuyek - Center Valley PA, US
Yanchun Wang - Newton MA, US
Suanne Nakajima - Winchester MA, US
Ly Tam Phan - Quincy MA, US
Yat Sun Or - Watertown MA, US
Yao-Ling Qiu - Andover MA, US
Deqiang Niu - Lexington MA, US
Yulin Peng - Waltham MA, US
Marina Busuyek - Center Valley PA, US
Yanchun Wang - Newton MA, US
Suanne Nakajima - Winchester MA, US
International Classification:
C07H 17/08
US Classification:
536 74, 536 72
Abstract:
The present invention discloses compounds of formula I, or pharmaceutically acceptable salts, esters, or prodrugs thereof:which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of antibiotic treatment. The invention also relates to methods of treating a bacterial infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The invention further includes processes by which to make the compounds of the present invention.
9A, 11-3C-Bicyclic 9A-Azalide Derivatives
US Patent:
7276487, Oct 2, 2007
Filed:
Sep 21, 2004
Appl. No.:
10/946339
Inventors:
Guoqiang Wang - Belmont MA, US
Yulin Peng - Waltham MA, US
Yanchun Wang - Newton MA, US
Ly Tam Phan - Quincy MA, US
Yat Sun Or - Watertown MA, US
Yulin Peng - Waltham MA, US
Yanchun Wang - Newton MA, US
Ly Tam Phan - Quincy MA, US
Yat Sun Or - Watertown MA, US
Assignee:
Enanta Pharmaceuticals, Inc. - Watertown MA
International Classification:
A61K 31/70, C07H 17/08
US Classification:
514 29, 536 74
Abstract:
The present invention discloses compounds of formula I, or pharmaceutically acceptable salts, esters, or prodrugs thereof:.
9A, 11-2C-Bicyclic 9A-Azalide Derivatives
US Patent:
7271155, Sep 18, 2007
Filed:
Jan 3, 2006
Appl. No.:
11/324502
Inventors:
Yat Sun Or - Watertown MA, US
Ly Tam Phan - Quincy MA, US
Guoqiang Wang - Belmont MA, US
Yanchun Wang - Newton MA, US
Yulin Peng - Waltham MA, US
Ly Tam Phan - Quincy MA, US
Guoqiang Wang - Belmont MA, US
Yanchun Wang - Newton MA, US
Yulin Peng - Waltham MA, US
Assignee:
Enanta Pharmaceuticals, Inc. - Watertown MA
International Classification:
A61K 31/70, C07H 17/08
US Classification:
514 29, 536 74
Abstract:
The present invention discloses compounds of formulae I and II, or pharmaceutically acceptable salts, esters, or prodrugs thereof:.